|
The
UAF Institutional Biosafety Committee was established in February 2001,
by then Chancellor Marshall Lind. This committee was tasked with providing
oversight and guidance for all campus needs related to research and teaching
involving the use of recombinant DNA, artificial gene transfer, infectious
agents, and biologically derived toxins. The Institutional Biosafety
Committee's scope has been further expanded to include providing faculty
input to the UAF Department of Environmental Health, Safety & Risk
Management's Lab Safety Group with respect to implementation of the university's
Chemical Hygiene Plan.
University researchers are required to obtain
prior approval for all work involving the following:
Recombinant DNA and Artificial
Gene Transfers (including gene therapy clinical trials and
the creation of transgenic animals).
Infectious Agents. Note:
This is not limited to human infectious agents.
Biologically Derived Toxins.
This includes any agent listed on a "Select Agent List" by
any federal agency. Examples include, but are not limited to, endotoxins,
staphylococcus enterotoxins, saxitoxin, cholera toxin, botulinum toxin,
ricin, abrin, and venoms.
Researchers
must submit an IBC Biosafety Registration to the Office of Research Integrity.
The ORI serves as administrative support for the IBC and will handle
all communication between the IBC and principal investigators. ORI staff
will conduct an administrative review to insure that the application
is complete before placing the application on the IBC schedule.
Note: All researchers
need to be aware that the federal government has placed restrictions
on who may have access to select agents. Likewise, federal law prohibits
the export (which includes access by or transfer to foreign nationals
within the US) of select agents without the appropriate permits. Certain
other chemicals and agents which are not on the Select Agent Lists have
access and transfer restrictions imposed under US Export Regulations.
If you have questions about export compliance contact the Office of Research
Integrity for more information.
|
